교육시간 |
2019-08-30 |
09:30~09:50 |
GVHD prophylaxis with post CY after haplo-identical , matched unelated, and HLA-identical stem cell transplantation |
Nicolaus Kr?ger |
USA |
교육시간 |
2019-08-30 |
09:50~10:10 |
Future changes in Stem Cell Transplantation and Cellular Therapy: Safer, Less toxic and Less Costly approaches |
Daniel Weisdorf |
USA |
교육시간 |
2019-08-30 |
10:10~10:30 |
Novel approaches for treating and preventing GvHD |
John F. DiPersio |
USA |
교육시간 |
2019-08-30 |
10:30~10:50 |
Design the future of hematopoietic cell transplantation in Asia-Pacific countries/regions |
Shinichiro Okamoto |
Japan |
교육시간 |
2019-08-30 |
11:00~11:40 |
HSC genetic modification to model human diseases and develop new therapy |
Cynthia E. Dunbar |
USA |
교육시간 |
2019-08-30 |
11:40~12:20 |
Outcome of unmanipulated haploidentical transplants in leukemia : an update on 500 patients |
Andrea Bacigalupo |
Italy |
교육시간 |
2019-08-30 |
12:30~13:30 |
런천심포지엄 |
David Kuter |
USA |
교육시간 |
2019-08-30 |
14:30~15:00 |
Identification of high-risk AML |
Hiroki Yamaguchi |
Japan |
교육시간 |
2019-08-30 |
15:00~15:30 |
Prediction of post-SCT outcome |
Je-Hwan Lee |
KOREA |
교육시간 |
2019-08-30 |
15:30~16:00 |
Personalized application of SCT for adult AML |
Shingo Yano |
Japan |
교육시간 |
2019-08-30 |
16:00~16:30 |
Tailored therapy for pediatric AML |
Jae Wook Lee |
Korea |
교육시간 |
2019-08-30 |
17:00~17:30 |
Pros and cons on the role of upfront auto-SCT for peripheral T-cell lymphoma |
Lim Soon Thye |
Sigapore |
교육시간 |
2019-08-30 |
17:30~18:00 |
Pros and cons on the role of upfront auto-SCT for primary CNS lymphoma |
Dok Hyun Yoon |
Korea |
교육시간 |
2019-08-31 |
09:00~09:30 |
New directions in GVHD prophylaxis |
Marie-Th?r?se Rubiob |
France |
교육시간 |
2019-08-31 |
09:30~10:00 |
New agents in GVHD treatment |
Robert Zeiser |
Germany |
교육시간 |
2019-08-31 |
10:00~10:30 |
Cancer immunotherapy in neuroblastoma |
Alice L. Yu |
Taiwan |
교육시간 |
2019-08-31 |
10:30~11:00 |
Update of high-risk neuroblastoma treatment |
Ki Woong Sung |
Korea |
교육시간 |
2019-08-31 |
11:00~11:30 |
The influence of microbiome on GVHD and relapse of primary disease |
Van den Brin |
USA |
교육시간 |
2019-08-31 |
11:30~12:00 |
FMT for refractory GVHD |
Young-Seok Cho |
Korea |
교육시간 |
2019-08-31 |
12:00~13:00 |
How to Improve Survival Rates for Patients Undergoing HSCT : Successful Management of VOD/SOS |
Donal McLornan |
UK |
교육시간 |
2019-08-31 |
13:00~13:30 |
HSCT in immune dysregulation syndromes: When and how? |
Shanmuganathan Chandrakasan |
USA |
교육시간 |
2019-08-31 |
13:30~14:00 |
Unanswered questions in HSCT for primary immunodficiecny |
Keon Hee Yoo |
Korea |
교육시간 |
2019-08-31 |
14:00~14:30 |
Genome editing using CRISPR |
Hyongbum Kim |
Korea |
교육시간 |
2019-08-31 |
14:30~15:00 |
Clinical application of CRISPR-Cas system |
Yongsub Kim |
Korea |
교육시간 |
2019-08-31 |
16:30~17:30 |
Something Fun through Beer |
SangJoon Pae |
Korea |
교육시간 |
2019-09-01 |
09:00~09:30 |
The role of hematopoietic stem cell transplantation in nuclear or radiation accidents(tentative name) |
hyo Rak Lee |
Korea |
교육시간 |
2019-09-01 |
09:30~10:00 |
Role of hematologist in radiation/nuclear emergency: an experience of the Tokai-mura accident |
Makoto Akashi |
Japan |
교육시간 |
2019-09-01 |
10:00~10:30 |
Cytopenia: Clonal vs immune-a guide to investigation and management |
Austin G. Kulasekararaj |
UK |
교육시간 |
2019-09-01 |
10:30~11:00 |
Hematopoietic stem cell based gene therapy for blood diseases |
Alok Srivastava |
India |
교육시간 |
2019-09-01 |
11:00~11:30 |
Prognostic significance of NGS-based minimal residual disease in the setting of SCT in leukemia:
Role of innovative therapeutic modalities |
Borahm Kim |
Korea |
교육시간 |
2019-09-01 |
11:30~12:00 |
A practical application and limitation of NGS based HLA typing for SCT |
Yun Ji Hong |
Korea |